Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients

BACKGROUND: Proton-pump-inhibitors (PPIs) are frequently prescribed for the management of anticancer drug-related gastrointestinal symptoms. Palbociclib is a weak base with pH-dependent solubility and potential drug-drug interaction at the absorption level may affect clinical pharmacokinetics. The c...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Re, M., Omarini, C., Diodati, L., Palleschi, M., Meattini, I., Crucitta, S., Lorenzini, G., Isca, C., Fontana, A., Livi, L., Piacentini, F., Fogli, S., De Giorgi, U., Danesi, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441157/
https://www.ncbi.nlm.nih.gov/pubmed/34509802
http://dx.doi.org/10.1016/j.esmoop.2021.100231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441157/
https://www.ncbi.nlm.nih.gov/pubmed/34509802
http://dx.doi.org/10.1016/j.esmoop.2021.100231

Ejemplares similares